Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 11629090 | HCID 11629090 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 69061257 | HCID 69061257 | — |
Reaction Steps
0.5 g (0.69 mmol) (R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate are dissolved in 5 ml of ethanol at ambient temperature and combined with 78 μl hydrobromic acid (48% in water). The mixture is heated to 70° C., whereupon a light yellow solution is formed. This solution is stirred for 3 days at 50° C., during which time a white precipitate is formed. After cooling to ambient temperature the solid formed is filtered off and dried for 12 hours at 40° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07638625B2 |
|---|
| Source dataset | uspto-grants-2009_12 |
|---|
| ORD ID | ord-93ad965cca2b4a0e8251d652d023b638 |
|---|
| Source note | uspto-grants-2009_12 |
|---|